LIFECELL CORPORATION
Financial Highlights
(Unaudited)
(In thousands, except for
per share data) Three Months Ended Year Ended
December 31, December 31,
Statement of Operations Data: 2007 2006 2007 2006
Revenues:
Product revenues $52,599 $39,337 $190,518 $140,647
Research grant revenues - 292 612 1,033
Total revenues 52,599 39,629 191,130 141,680
Costs and Expenses:
Cost of products sold 15,646 11,022 56,090 40,856
Research and development 6,547 4,889 23,547 16,500
General and administrative 8,773 4,762 24,580 18,618
Selling and marketing 12,314 9,553 43,480 32,376
Total costs and expenses 43,280 30,226 147,697 108,350
Income from operations 9,319 9,403 43,433 33,330
Interest and other income
(expense), net 912 865 4,028 2,793
Income before income taxes 10,231 10,268 47,461 36,123
Income tax provision 4,754 4,042 20,578 15,654
Net income $5,477 $6,226 $26,883 $20,469
Net income per common share:
Basic $0.16 $0.19 $0.81 $0.62
Diluted $0.16 $0.18 $0.78 $0.60
Shares used in computing
net income per common share:
Basic 33,565 32,977 33,345 32,769
Diluted 34,817 34,113 34,534 34,007
(In thou
'/>"/>
| SOURCE LifeCell Corporation Copyright©2008 PR Newswire. All rights reserved |